BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 15655386)

  • 1. Hypertension management: differing points of view. Should we routinely measure renin levels to diagnose and treat patients with hypertension? The argument against.
    Weinberger MH
    J Clin Hypertens (Greenwich); 2005 Jan; 7(1):36-7; quiz 38-9. PubMed ID: 15655386
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypertension management: differing points of view. Should we routinely measure renin levels to diagnose and treat patients with hypertension? The argument for.
    August P
    J Clin Hypertens (Greenwich); 2005 Jan; 7(1):33-5; quiz 38-9. PubMed ID: 15655385
    [No Abstract]   [Full Text] [Related]  

  • 3. Is there overlap in blood-pressure response to the blockers of the renin-angiotensin system between lower and higher renin subjects?
    Minami J; Ishimitsu T; Matsuoka H
    Am J Hypertens; 2008 Feb; 21(2):130-1; author reply 132. PubMed ID: 18268482
    [No Abstract]   [Full Text] [Related]  

  • 4. Does aldosterone-to-renin ratio predict the antihypertensive effect of the aldosterone antagonist spironolactone?
    Mahmud A; Mahgoub M; Hall M; Feely J
    Am J Hypertens; 2005 Dec; 18(12 Pt 1):1631-5. PubMed ID: 16364838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physiologic tailoring of therapy for resistant hypertension: 20 years' experience with stimulated renin profiling.
    Spence JD
    Am J Hypertens; 1999 Nov; 12(11 Pt 1):1077-83. PubMed ID: 10604483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hypertension and renin/angiotensin. Physiopathological and therapeutical aspects].
    Jorgensen H
    Tidsskr Nor Laegeforen; 1975 Dec; 95(34-36):1988-91. PubMed ID: 1209575
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasma renin activity and systemic arterial hypertension.
    Kirkendall WM; Overturf M
    Mod Concepts Cardiovasc Dis; 1973 Oct; 42(10):47-52. PubMed ID: 4784809
    [No Abstract]   [Full Text] [Related]  

  • 8. Interaction between serum cholesterol levels and the renin-angiotensin system on the new onset of arterial hypertension in subjects with high-normal blood pressure.
    Borghi C; Veronesi M; Cosentino E; Cicero AF; Kuria F; Dormi A; Ambrosioni E
    J Hypertens; 2007 Oct; 25(10):2051-7. PubMed ID: 17885547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct renin inhibition with aliskiren in hypertension and target organ damage.
    Müller DN; Luft FC
    Clin J Am Soc Nephrol; 2006 Mar; 1(2):221-8. PubMed ID: 17699210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma renin measurement in the management of hypertension: the V and R hypothesis.
    Moser M; Izzo JL
    J Clin Hypertens (Greenwich); 2003; 5(6):373-6. PubMed ID: 14688491
    [No Abstract]   [Full Text] [Related]  

  • 11. Importance of renin in blood pressure regulation and therapeutic potential of renin inhibition.
    Ferro A; Gilbert R; Krum H
    Int J Clin Pract; 2006 May; 60(5):577-81. PubMed ID: 16700858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renin inhibition in hypertension.
    Gradman AH; Kad R
    J Am Coll Cardiol; 2008 Feb; 51(5):519-28. PubMed ID: 18237679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renin inhibition: the holy grail of renin-angiotensin system blockade?
    McInnes GT
    J Hum Hypertens; 2007 Oct; 21(10):766-9. PubMed ID: 17541389
    [No Abstract]   [Full Text] [Related]  

  • 15. Pretreatment levels of plasma renin activity predict ambulatory blood pressure response to valsartan in essential hypertension.
    Minami J; Ohno E; Furukata S; Ishimitsu T; Matsuoka H
    J Hum Hypertens; 2009 Oct; 23(10):683-6. PubMed ID: 19369955
    [No Abstract]   [Full Text] [Related]  

  • 16. Aliskiren, the first approved renin inhibitor: Clinical application and safety in the treatment of hypertension.
    Riccioni G; Vitulano N; D'Orazio N; Bellocci F
    Adv Ther; 2009 Jul; 26(7):700-10. PubMed ID: 19649581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of arterial hypertension patients depending on renin activity].
    Naugol'nova SB; Lapshina LA
    Vrach Delo; 1984 Feb; (2):61-5. PubMed ID: 6372240
    [No Abstract]   [Full Text] [Related]  

  • 18. Aliskiren: renin inhibitor for hypertension management.
    Cheng JW
    Clin Ther; 2008 Jan; 30(1):31-47. PubMed ID: 18343241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension].
    Abassi Z; Armaly Z; Nakhoul F; Hoffman A
    Harefuah; 2008 Jun; 147(6):536-42, 573. PubMed ID: 18693632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aliskiren, the future of renin-angiotensin system blockade?
    Uresin Y; Mehtar Bozkurt M; Sabirli S; Ozunal ZG
    Expert Rev Cardiovasc Ther; 2007 Sep; 5(5):835-49. PubMed ID: 17867914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.